SCI & TECH● LOWJul 15 · Jul 15, 2026, 3:43 PM
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Yahoo Finance
Larimar Therapeutics (LRMR) has submitted the initial module of its Biologics License Application (BLA) for Nomlabofusp Therapy.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH30m agoMeta Launches New ‘Open’ AI Model To Rival Chinese CompetitionChannels TVSCI & TECH30m agoMeta unveils new ‘open’ AI model to rival Chinese competitionVanguard NigeriaSCI & TECH53m agoAnavex Life Sciences gains IND clearance for blarcamesine in Fragile X syndromeSeeking Alpha TechSCI & TECH57m agoAstra | The latest leapThe Hindu